Skip to main content
Study

Impact of pharmacist previsit input to providers on chronic opioid prescribing safety.

Cox N, Tak CR, Cochella SE, et al. Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety. The Journal of the American Board of Family Medicine. 2018;31(1). doi:10.3122/jabfm.2018.01.170210.

Save

Print

March 14, 2018
Cox N, Tak CR, Cochella SE, et al. The Journal of the American Board of Family Medicine. 2018;31.

In this pilot study, a clinical pharmacist reviewed charts for adult patients with chronic pain who were prescribed more than 50 morphine milligram equivalents per day and made prescribing recommendations to providers before patient appointments. The intervention led to a 14% decrease in morphine milligram equivalents per day without a change in pain reported by patients and improved adherence to prescribing guidelines.

Save

Print

Cite
Citation

Cox N, Tak CR, Cochella SE, et al. Impact of Pharmacist Previsit Input to Providers on Chronic Opioid Prescribing Safety. The Journal of the American Board of Family Medicine. 2018;31(1). doi:10.3122/jabfm.2018.01.170210.